Legitimo Annalisa, Consolini Rita, Bencivelli Walter, Crimaldi Gaetano, Migliaccio Pasquale, Mosca Franco
Department of Pediatrics and Reproductive Medicine, University of Pisa, Pisa, Italy.
Acta Haematol. 2006;116(3):192-7. doi: 10.1159/000094680.
Photopheresis or extracorporeal photochemotherapy (ECP) is a new immunomodulatory therapy in which a patient's leukocytes are exposed extracorporeally to 8-methoxypsoralen (8-MOP) and ultraviolet A (UVA) light. Although it is used for the treatment of cutaneous T cell lymphoma, graft-versus-host disease, and several autoimmune diseases, with efficacy and safety reported in almost all studies, the mechanisms by which ECP exerts its beneficial effects are still unclear. As cellular targets of this procedure are numerous, we investigated the effects of 8-MOP and UVA light on stromal precursors and mature stromal layers. Human bone marrow stromal cell layers were established in long-term bone marrow culture medium from normal marrow mononuclear cells. Normal marrow mononuclear cells were incubated with 8-MOP and/or exposed to UVA light (PUVA treatment) before culturing. A control without 8-MOP and UVA was also included in the study. Apoptosis induction was evaluated using annexin V following 7 days after PUVA. After 4-6 weeks of culture, stromal layers were examined under a phase-contrast microscope to identify structural differences between PUVA-treated and control stroma. To determine whether PUVA treatment affected stromal regulation of adherent hematopoietic cell survival, mature stromal layers, incubated with 8-MOP and exposed to UVA light, were cocultured with nonadherent mononuclear cells from normal marrow. After 24 h, the percentage of apoptotic hematopoietic cell precursors was quantified by flow cytometry. This study provides evidences that the in vitro exposure of human stromal cell precursors to UVA light, in the presence of 8-MOP, inhibits stromal layer generation by inducing apoptosis, as evidenced by annexin V staining following 7 days of culture. Here, we show an additional cell target for this psoralen following UVA irradiation. However, in a second set of experiments, PUVA treatment did not affect the stromal capacity to support hematopoiesis in culture. Our results can contribute to a better definition of ECP mechanisms of action for future development of experimental designs and clinical applications of this intriguing procedure.
光化学疗法或体外光化学疗法(ECP)是一种新型免疫调节疗法,即把患者的白细胞在体外暴露于8-甲氧基补骨脂素(8-MOP)和紫外线A(UVA)光下。尽管它用于治疗皮肤T细胞淋巴瘤、移植物抗宿主病和几种自身免疫性疾病,几乎所有研究都报告了其有效性和安全性,但ECP发挥有益作用的机制仍不清楚。由于该程序的细胞靶点众多,我们研究了8-MOP和UVA光对基质前体细胞和成熟基质层的影响。从正常骨髓单个核细胞在长期骨髓培养基中建立人骨髓基质细胞层。正常骨髓单个核细胞在培养前与8-MOP孵育和/或暴露于UVA光(PUVA处理)。该研究还包括一个不进行8-MOP和UVA处理的对照组。PUVA处理7天后,使用膜联蛋白V评估凋亡诱导情况。培养4-6周后,在相差显微镜下检查基质层,以确定PUVA处理的基质与对照基质之间的结构差异。为了确定PUVA处理是否影响基质对贴壁造血细胞存活的调节,将用8-MOP孵育并暴露于UVA光的成熟基质层与来自正常骨髓的非贴壁单个核细胞共培养。24小时后,通过流式细胞术对凋亡造血细胞前体的百分比进行定量。本研究提供的证据表明,在8-MOP存在的情况下,人基质前体细胞体外暴露于UVA光通过诱导凋亡抑制基质层生成,培养7天后膜联蛋白V染色证明了这一点。在这里,我们展示了这种补骨脂素在UVA照射后的另一个细胞靶点。然而,在第二组实验中,PUVA处理不影响培养中基质支持造血的能力。我们的结果有助于更好地定义ECP的作用机制,以便为该有趣程序的实验设计和临床应用的未来发展提供参考。